Target intelligence / Profile preview

Crotalinae venom toxins

Molecular classification
Enzyme, Snake venom metalloproteinase, Phospholipase A2, Serine protease, C-type lectin-like protein, Disintegrin
01

Overview

Crotalinae venom toxins represent a diverse array of bioactive proteins and peptides secreted by pit vipers, such as rattlesnakes, copperheads, and cottonmouths [1]. The primary toxic constituents include snake venom metalloproteinases (SVMPs), which degrade extracellular matrix components leading to hemorrhage; phospholipases A2 (PLA2s), which cause cell membrane damage and inflammation; and serine proteases that interfere with the coagulation cascade [1][4]. Envenomation by these species typically results in local tissue damage, systemic coagulopathy, and occasionally neurotoxicity or myotoxicity [4][5]. Therapeutic management relies on antivenoms, which are composed of purified antibodies or antibody fragments (Fab or F(ab')2) derived from immunized animals [2][3]. These antivenoms function by binding to and neutralizing the circulating toxins, thereby halting the progression of systemic and local symptoms [2][3].

Other names
Pit viper venom toxinsCrotalid venomRattlesnake venom toxinsCrotalinae snake venom
02

Mechanism of action

The mechanism of action involves passive immunization where the antivenom's Fab or F(ab')2 fragments bind to the venom's antigenic sites, neutralizing the toxins' enzymatic and toxicological activities and facilitating their redistribution and elimination from the body [2][3][5].

03

Biological functions

ProteolysisHemolysisCoagulation modulationMyotoxicityNeurotoxicityPlatelet aggregation inhibition
04

Disease associations

Snakebite envenomationHemorrhageCoagulopathyTissue necrosisThrombocytopenia
05

Safety considerations

AnaphylaxisSerum sicknessHypersensitivity reactionsRecurrent venom effects (rebound)
06

Interacting drugs

Crotalidae Polyvalent Immune Fab (Ovine)

2 more in the full profile.

07

Biomarkers

Prothrombin time (PT)Fibrinogen levelPlatelet countCreatine kinase (CK)Partial thromboplastin time (PTT)

Beyond the preview

Go deeper on Crotalinae venom toxins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crotalinae venom toxins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call